Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001214659-16-010923
Filing Date
2016-04-20
Accepted
2016-04-20 16:31:00
Documents
4
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 g42016110ka1.htm 10-K/A 41099
2 EXHIBIT 23.1 ex23_1.htm EX-32.2 4224
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 6821
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 7324
  Complete submission text file 0001214659-16-010923.txt   60481
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

EIN.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34637 | Film No.: 161581681
SIC: 2834 Pharmaceutical Preparations